q80km9_hcmv
NAME
5WB2
ORGANISM
strain AD169 (Human cytomegalovirus)
PROTEIN NAME
q80km9_hcmv
SOURCE
TREMBL
SEQUENCE
Perspective:
Wild-type
Construct
N-term | |||||||||
M
|
T
|
P
|
T
|
T
|
T
|
T
|
A
|
E
|
L
|
10 |
T
|
T
|
E
|
F
|
D
|
Y
|
D
|
E
|
D
|
A
|
20 |
TM1 | |||||||||
T
|
P
|
C
|
V
|
F
|
T
|
D
|
V
|
L
|
N
|
30 |
Q
|
S
|
K
|
P
|
V
|
T
|
L
|
F
|
L
|
Y
|
40 |
G
|
V
|
V
|
F
|
L
|
F
|
G
|
S
|
I
|
G
|
50 |
N
|
F
|
L
|
V
|
I
|
F
|
T
|
I
|
T
|
W
|
60 |
ICL1 | TM2 | ||||||||
R
|
R
|
R
|
I
|
Q
|
C
|
S
|
G
|
D
|
V
|
70 |
Y
|
F
|
I
|
N
|
L
|
A
|
A
|
A
|
D
|
L
|
80 |
L
|
F
|
V
|
C
|
T
|
L
|
P
|
L
|
W
|
M
|
90 |
ECL1 | |||||||||
Q
|
Y
|
L
|
L
|
D
|
H
|
N
|
S
|
L
|
A
|
100 |
TM3 | |||||||||
S
|
V
|
P
|
C
|
T
|
L
|
L
|
T
|
A
|
C
|
110 |
F
|
Y
|
V
|
A
|
M
|
F
|
A
|
S
|
L
|
C
|
120 |
F
|
I
|
T
|
E
|
I
|
A
|
L
|
D
|
R
|
Y
|
130 |
ICL2 | |||||||||
Y
|
A
|
I
|
V
|
Y
|
M
|
R
|
Y
|
R
|
P
|
140 |
TM4 | |||||||||
V
|
K
|
Q
|
A
|
C
|
L
|
F
|
S
|
I
|
F
|
150 |
W
|
W
|
I
|
F
|
A
|
V
|
I
|
I
|
A
|
I
|
160 |
ECL2 | |||||||||
P
|
H
|
F
|
M
|
V
|
V
|
T
|
K
|
K
|
D
|
170 |
N
|
Q
|
C
|
M
|
T
|
D
|
Y
|
D
|
Y
|
L
|
180 |
TM5 | |||||||||
E
|
V
|
S
|
Y
|
P
|
I
|
I
|
L
|
N
|
V
|
190 |
E
|
L
|
M
|
L
|
G
|
A
|
F
|
V
|
I
|
P
|
200 |
L
|
S
|
V
|
I
|
S
|
Y
|
C
|
Y
|
Y
|
R
|
210 |
I
|
S
|
R
|
I
|
V
|
A
|
V
|
S
|
Q
|
S
|
220 |
ICL3 | TM6 | ||||||||
R
|
H
|
K
|
G
|
R
|
I
|
V
|
R
|
V
|
L
|
230 |
I
|
A
|
V
|
V
|
L
|
V
|
F
|
I
|
I
|
F
|
240 |
W
|
L
|
P
|
Y
|
H
|
L
|
T
|
L
|
F
|
V
|
250 |
D
|
T
|
L
|
K
|
L
|
L
|
K
|
W
|
I
|
S
|
260 |
ECL3 | TM7 | ||||||||
S
|
S
|
C
|
E
|
F
|
E
|
R
|
S
|
L
|
K
|
270 |
R
|
A
|
L
|
I
|
L
|
T
|
E
|
S
|
L
|
A
|
280 |
F
|
C
|
H
|
C
|
C
|
L
|
N
|
P
|
L
|
L
|
290 |
H8 | |||||||||
Y
|
V
|
F
|
V
|
G
|
T
|
K
|
F
|
R
|
Q
|
300 |
E
|
L
|
H
|
C
|
L
|
L
|
A
|
E
|
F
|
R
|
310 |
|
|
|
|
|
|
|
|
|
|
C-term | |||||||||
Q
|
R
|
L
|
F
|
S
|
R
|
D
|
V
|
S
|
W
|
320 |
|
|
|
|
|
|
|
|
|
|
Y
|
H
|
S
|
M
|
S
|
F
|
S
|
R
|
R
|
G
|
330 |
|
|
|
|
|
|
|
|
|
|
S
|
P
|
S
|
R
|
R
|
E
|
T
|
S
|
S
|
D
|
340 |
|
|
|
|
|
|
|
|
|
|
T
|
L
|
S
|
D
|
E
|
V
|
C
|
R
|
V
|
S
|
350 |
|
|
|
|
Q
|
I
|
I
|
P
|
|
|
|
|
|
|
|
|
|
|
|
hemagglutin | ||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
FLAG | |||||||||
|
|
|
|
|
|
|
|
|
|
N-term | |||||||||
M
|
T
|
P
|
T
|
T
|
T
|
T
|
A
|
E
|
L
|
10 |
T
|
T
|
E
|
F
|
D
|
Y
|
D
|
E
|
D
|
A
|
20 |
TM1 | |||||||||
T
|
P
|
C
|
V
|
F
|
T
|
D
|
V
|
L
|
N
|
30 |
Q
|
S
|
K
|
P
|
V
|
T
|
L
|
F
|
L
|
Y
|
40 |
G
|
V
|
V
|
F
|
L
|
F
|
G
|
S
|
I
|
G
|
50 |
N
|
F
|
L
|
V
|
I
|
F
|
T
|
I
|
T
|
W
|
60 |
ICL1 | TM2 | ||||||||
R
|
R
|
R
|
I
|
Q
|
C
|
S
|
G
|
D
|
V
|
70 |
Y
|
F
|
I
|
N
|
L
|
A
|
A
|
A
|
D
|
L
|
80 |
L
|
F
|
V
|
C
|
T
|
L
|
P
|
L
|
W
|
M
|
90 |
ECL1 | |||||||||
Q
|
Y
|
L
|
L
|
D
|
H
|
N
|
S
|
L
|
A
|
100 |
TM3 | |||||||||
S
|
V
|
P
|
C
|
T
|
L
|
L
|
T
|
A
|
C
|
110 |
F
|
Y
|
V
|
A
|
M
|
F
|
A
|
S
|
L
|
C
|
120 |
F
|
I
|
T
|
E
|
I
|
A
|
L
|
D
|
R
|
Y
|
130 |
ICL2 | |||||||||
Y
|
A
|
I
|
V
|
Y
|
M
|
R
|
Y
|
R
|
P
|
140 |
TM4 | |||||||||
V
|
K
|
Q
|
A
|
C
|
L
|
F
|
S
|
I
|
F
|
150 |
W
|
W
|
I
|
F
|
A
|
V
|
I
|
I
|
A
|
I
|
160 |
ECL2 | |||||||||
P
|
H
|
F
|
M
|
V
|
V
|
T
|
K
|
K
|
D
|
170 |
N
|
Q
|
C
|
M
|
T
|
D
|
Y
|
D
|
Y
|
L
|
180 |
TM5 | |||||||||
E
|
V
|
S
|
Y
|
P
|
I
|
I
|
L
|
N
|
V
|
190 |
E
|
L
|
M
|
L
|
G
|
A
|
F
|
V
|
I
|
P
|
200 |
L
|
S
|
V
|
I
|
S
|
Y
|
C
|
Y
|
Y
|
R
|
210 |
I
|
S
|
R
|
I
|
V
|
A
|
V
|
S
|
Q
|
S
|
220 |
ICL3 | TM6 | ||||||||
R
|
H
|
K
|
G
|
R
|
I
|
V
|
R
|
V
|
L
|
230 |
I
|
A
|
V
|
V
|
L
|
V
|
F
|
I
|
I
|
F
|
240 |
W
|
L
|
P
|
Y
|
H
|
L
|
T
|
L
|
F
|
V
|
250 |
D
|
T
|
L
|
K
|
L
|
L
|
K
|
W
|
I
|
S
|
260 |
ECL3 | TM7 | ||||||||
S
|
S
|
C
|
E
|
F
|
E
|
R
|
S
|
L
|
K
|
270 |
R
|
A
|
L
|
I
|
L
|
T
|
E
|
S
|
L
|
A
|
280 |
F
|
C
|
H
|
C
|
C
|
L
|
N
|
P
|
L
|
L
|
290 |
H8 | |||||||||
Y
|
V
|
F
|
V
|
G
|
T
|
K
|
F
|
R
|
Q
|
300 |
|
|||||||||||||||||||||
E
|
L
|
H
|
C
|
L
|
L
|
A
|
E
|
F
|
R
|
|
|||||||||||
310 |
|
|
|
|
|
|
|
|
|
|
|
ThrombinSit | ||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GGSGGS | |||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ThrombinSit | ||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nanobody7 | |||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PreScission | ||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Protein C | |||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
His(8) | |||||||||
|
|
|
|
|
|
|
|
|
|
SCHEMATIC
Perspective:
Wild-type
Construct
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
DIAGRAMS
MUTATIONS
Position | Wild-type | Mutated |
---|
DELETIONS
MODIFICATIONS
AUXILIARY PROTEINS
Protein_type: signal
Name: hemagglutinin
Sequence: None
Deletions:
Positions: N-term_0 None:None
Presence in Crystal:NO
Remarks: None
Protein_type: tag
Name: FLAG
Sequence: None
Deletions:
Positions: N-term_1 None:None
Presence in Crystal:YES
Remarks: None
Protein_type: prot_cleavage
Name: ThrombinSite(LVPRGS)
Sequence: None
Deletions:
Positions: C-term_2 None:None
Presence in Crystal:YES
Remarks: None
Protein_type: linker
Name: GGSGGS
Sequence: None
Deletions:
Positions: C-term_3 None:None
Presence in Crystal:YES
Remarks: None
Protein_type: prot_cleavage
Name: ThrombinSite(LVPRGS)
Sequence: None
Deletions:
Positions: C-term_4 None:None
Presence in Crystal:YES
Remarks: None
Protein_type: fusion
Name: Nanobody7
Sequence: None
Deletions:
Positions: C-term_5 None:None
Presence in Crystal:YES
Remarks: None
Protein_type: prot_cleavage
Name: PreScission site (3C)
Sequence: None
Deletions:
Positions: C-term_6 None:None
Presence in Crystal:NO
Remarks: None
Protein_type: linker
Name: Protein C
Sequence: None
Deletions:
Positions: C-term_7 None:None
Presence in Crystal:NO
Remarks: None
Protein_type: tag
Name: His(8)
Sequence: None
Deletions:
Positions: C-term_8 None:None
Presence in Crystal:NO
Remarks: None
EXPRESSION
Expression method | Host cell type | Host cell | Remarks |
---|---|---|---|
Baculovirus | HEK293S(TetR)-GnTI- | Mammalian | BacMam baculovirus transduct |
SOLUBILIZATION
Solvent type | Item | Concentration |
---|---|---|
detergent | DDM | 1 %w/v |
additive | CHS | 0.2 %w/v |
Remarks:
PURIFICATION
Purification type | Description |
---|---|
Alkylation by Iodoacetamide | None |
Proteolysis by HRV 3C protease | None |
Remarks:None
CRYSTALLIZATION
METHOD: in meso/LCP
TYPE: lipidic cubic phase (LCP) (monoolein (9.9 MAG))
PROTEIN CONCENTRATION: 28.0 mg/ml
Temperature: 16-20°C
ph : 6.0-6.0
Remarks: ligand CXCL1.35, with Nb7
Chemical lists
Type | Item | Concentration |
---|---|---|
Detergent | ||
DDM | 0.02 % w/v | |
Lipid | ||
CHS | 0.004 % w/v | |
Additional | ||
MES pH 6.0 | NA NA | |
lithium sulfate | 50.0 mM | |
PEG 300 | 35-39 % v/v | |
1,2,3-heptanetriol | 1.0 % v/v | |
Carboxypeptidase A & B | 1:150 (w/w) |